|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
99 High Street, 30th Floor, Boston, MA 02110, US
|
|
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis is applying insights into the genetic mutations that drive excitation-inhibition imbalance in diseases to select biological targets for rare and more prevalent neurological disorders.
We share a common vision of reshaping the human condition into a more freeing and fulfilled existence by developing high impact medicines for patients and families affected by and living with complex brain disorders.
Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using our understanding of shared biological targets and circuits in the brain.
|
Praxis Precision Medicines, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{first} | [email protected] |
75%
|
The widely used Praxis Precision Medicines, Inc. email format is {first} (e.g. [email protected]) with 75% adoption across the company.
To contact Praxis Precision Medicines, Inc. customer service number in your country click here to find.
Brian Spar is the CEO of Praxis Precision Medicines, Inc.. To contact Brian Spar email at [email protected]. Or you may call 973-901-1407
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.